Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-08-21

FDA Approved: VARITHENA — Supplemental Application (Biocompatibles, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for VARITHENA (polidocanol) from Biocompatibles, Inc., updating the product labeling/indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varithena (polidocanol injectable foam)

Snippet

SUPPL AP for VARITHENA (POLIDOCANOL)